Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Patent Publication Number 20190100589

US 20190100589 A1
Patent NumberUS 10266594 B1
Application Number16213954
Filled DateDec 7, 2018
Priority DateMay 15, 2012
Publication DateApr 4, 2019
Original AssigneeBristol Myers Squibb
Current AssigneeBristol Myers Squibb
Inventor/ApplicantsAshok K. Gupta
Xi-Tao Wang
John P. Cogswell
Maria Jure-Kunkel
Stacie M. Goldberg
Jon M. Wigginton
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.